You can buy or sell PLX and other stocks, options, and ETFs commission-free!
Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel. The listed name for PLX is Protalix BioTherapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 11, Pre-Market